Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.7900
-0.0500
(-5.95%)
As of 2:36:18 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.09M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEHR MARTIN A Chief Executive Officer | Purchase at price 0.84 per share. | Direct | 4,900 | Feb 21, 2023 |
Related Tickers
OVID Ovid Therapeutics Inc.
0.5761
-1.56%
IPSC Century Therapeutics, Inc.
0.7467
-1.53%
KTTA Pasithea Therapeutics Corp.
1.3500
+5.43%
ELEV Elevation Oncology, Inc.
0.6402
-1.54%
LPTX Leap Therapeutics, Inc.
0.4819
-1.65%
RLYB Rallybio Corporation
0.7500
-2.47%
DSGN Design Therapeutics, Inc.
4.9250
+1.13%
ENSC Ensysce Biosciences, Inc.
5.46
-3.53%
MRSN Mersana Therapeutics, Inc.
0.5306
-4.74%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
-7.14%